Home
Conditions
Hypersensitivity

Clinical trial condition

Hypersensitivity

Explore clinical trials studying Hypersensitivity. Study availability and eligibility vary by location and protocol.

6,776 public trials 652 recruiting studies

Refine in advanced search Browse all conditions

Hypersensitivity trial results

Completed

A Study of Icatibant (TAK-667) in Japanese Children and Teenagers With Acute Attacks of Hereditary Angioedema

NCT04654351

Conditions: Angioedema, Angioedemas, Hereditary, Cardiovascular Diseases, +14 more
Locations: Aich Medical University Hospital Nagakute, Aichi-ken, Japan

Juntendo University Hospital Bunkyo-ku, Tokyo, Japan

Kagoshima University Hospital Kagoshima, Japan

View Trial Details

Completed

Evaluation of Dupilumab in Children With Uncontrolled Asthma

NCT02948959

Conditions: Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations: Investigational Site Number 840031 Birmingham, Alabama, United States

Investigational Site Number 840002 Gilbert, Arizona, United States

Investigational Site Number 840012 Tucson, Arizona, United States

Investigational Site Number 840001 Rolling Hills Estates, California, United States

View all 99 locations

View Trial Details

Completed

Long-Term Safety Evaluation of Dupilumab in Patients With Asthma (LIBERTY ASTHMA TRAVERSE)

NCT02134028

Conditions: Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations: Investigational Site Number 840047 Birmingham, Alabama, United States

Investigational Site Number 840099 Gilbert, Arizona, United States

Investigational Site Number 840087 Scottsdale, Arizona, United States

Investigational Site Number 840402 Tucson, Arizona, United States

View all 365 locations

View Trial Details

Completed

Double-Masked Trial of NOVA22007 (1mg/mL Ciclosporin/Cyclosporine) Versus Vehicle in Pediatric Patients With Active Severe Vernal Keratoconjunctivitis

NCT01751126

Conditions: Conjunctival Diseases, Conjunctivitis, Conjunctivitis, Allergic, +5 more
Locations: Glendale, CA, USA Glendale, California, United States

Irvine, CA, USA Irvine, California, United States

Rancho Cordova, CA, USA Rancho Cordova, California, United States

Miami, FL, USA Miami, Florida, United States

View all 46 locations

View Trial Details

Completed

Study to Find Out How Long it Takes Azelastine Hydrochloride 0.15% Nasal Spray to Relieve Symptoms in Patients Suffering From Allergic Rhinitis

NCT04264637

Conditions: Allergic Rhinitis, Hypersensitivity, Hypersensitivity, Immediate, +7 more
Locations: Cliantha Research Mississauga, Ontario, Canada

View Trial Details

Completed

Evaluation of the Relapse Rate One Month After Discharge From Emergency Department for Asthmatic Patients Given a Strict Formalized Follow up Protocol

NCT02424409

Conditions: Asthma, Bronchial Diseases, Disease Attributes, +10 more
Locations: Service des Urgences, Hôpital Lariboisière Paris, France

View Trial Details

Completed

Biomarker for Hereditary AngioEdema Disease

NCT03029728

Conditions: Angio Edema, Angioedema, Angioedemas, Hereditary, +22 more
Locations: Arabkir JMC-ICAH Yerevan, Armenia

Center of Allergy and Immunology Tbilisi, Georgia

Department of Pediatric Genetics, Amrita Institute of Medical Sciences & Research Centre Kerola, India

Clinica San Pablo de Surco Lima, Peru

View Trial Details

Completed

Comparison of Innate Immune Responses Induced by Allergy Immunotherapy (AIT) With Different Adjuvants

NCT04104828

Conditions: Allergic Rhinitis, Hypersensitivity, Hypersensitivity, Immediate, +7 more
Locations: Univeristy Hospital Zurich Zurich, Switzerland

View Trial Details

Completed

Implementing Pathways to Improve Pediatric Asthma Care

NCT03736603

Conditions: Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations: University of California San Francisco, California, United States

View Trial Details

Completed

Effect of Inhaled TD-8236 on Allergen-induced Asthmatic Response

NCT04150341

Conditions: Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations: Theravance Biopharma Investigational Site London, United Kingdom

Theravance Biopharma Investigational Site Manchester, United Kingdom

View Trial Details

Hypersensitivity

Hypersensitivity trial results

Related conditions